Comparison about adverse drug reaction report forms among Asian's countries using herbal medicine

한약을 사용하는 아시아권 국가의 유해사례 보고 양식에 관한 비교 연구

  • Sun, Seung-Ho (Department of Korean Internal medicine, Colleg of Korean Medicine, Sang-ji University) ;
  • Lee, Eun-Kyoung (Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Jang, Bo-Hyoung (Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Park, Sunju (Department of Preventive Medicine, College of Korean Medicine, Daejeon University) ;
  • Go, Ho-Yeon (Department of Korean Internal Medicine, College of Korean Medicine, Semyung University) ;
  • Jeon, Chan-Yong (Department of Korean Internal Medicine, College of Korean Medicine, Gachon University) ;
  • Ko, Seong-Gyu (Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University)
  • 선승호 (상지대학교부속한방병원 한방내과) ;
  • 이은경 (경희대학교 예방의학교실) ;
  • 장보형 (경희대학교 예방의학교실) ;
  • 박선주 (대전대학교 한의과대학 예방의학교실) ;
  • 고호연 (세명대학교충주한방병원 한방내과) ;
  • 전찬용 (가천대학교 한의과대학 한방내과) ;
  • 고성규 (경희대학교 예방의학교실)
  • Received : 2015.11.19
  • Accepted : 2015.12.09
  • Published : 2015.12.31

Abstract

Objective : The purpose of this study is to find out the possibility of application to herbal medicine's report form for adverse drug reaction (ADR) by reviewing and analyzing Asian countries's ADR report forms. Method : We investigated, compared, and analyzed ADR report forms (ADR-RF) of Asian countries's ADR institutions (ACAI), such as, Korea institute of drug safety & risk management and Dongguk university Ilsan oriental hospital (DUIOH) in Korea, national center for ADR monintoring (NCAM) in China, pharmaceuticals and medical devices agency (PMDA) in Japan, Ministry of Health and Welfare (MOHW) in Taiwan, and drug office, department of health, the government of the Hong Kong special administrative region (GHKSAR) in Hong Kong. Results : ADR-RF for ACAI included common contents, such as, patients information (name(initial), gender, age, weight), adverse event (AE)'s report information (Recognition and report for AE occurrence, first or follow up report, Severe AE), the detailed information of AE (the title of AE, onset & closing date of AE symptoms, the progress & results detailed test of AE), the information of AE's medicine (the types of medicine, product name, ingredient name, suspected or combination drug, single dose & frequency, dosage form, administration route, dealing for AE-suspected medicine), and AE reporter's information (reporter's information, institution's information). Taiwan had ADR-RF and the department exclusively for herbal medicine (HM), but others (except DUIOH) had not only no ADR report form but also contents for HM. Conclusion : ADR-RF for HM have to include the common contents of ACAI at least, as well as HM information related to ADR, such as the title, composition and types of HM, history related to HM's ADR, and the contents of drug-induced liver injury and so on. In addition, the main department of government for HM's ADR will be needed.

Keywords

References

  1. 이종태. 한국인의 한약재 복용실태 조사 연구. 한양대학교: 식품의약품안전처, 2006. 과제번호 1470001444.
  2. Heinrich M, Chan J, Wanke S, Neinhuis C, Simmonds MS. Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2--a global assessment based on bibliographic sources. Journal of ethnopharmacology. 2009;125(1):108-44. https://doi.org/10.1016/j.jep.2009.05.028
  3. Suk KT, Kim DJ, Kim CH, Park SH, Yoon JH, Kim YS, et al. A prospective nationwide study of drug-induced liver injury in Korea. The American journal of gastroenterology. 2012;107(9):1380-7. https://doi.org/10.1038/ajg.2012.138
  4. 김미경, 한창호. 인터넷 신문기사에 보도된 한약유해사례 분석. 대한한의학회지. 2015;36(1):33-44. https://doi.org/10.13048/jkm.15004
  5. 배수현, 박상은, 강창완, 홍상훈. 한방병원 입원환자의 한양방 약물 병용에 따른 간 기능 안전성 평가 : 전향적 관찰연구. 대한한방내과학회지 2013;34(2):192-203.
  6. Zhou L, Liu L, Liu X, Chen P, Liu L, Zhang Y, et al. Systematic review and meta-analysis of the clinical efficacy and adverse effects of Chinese herbal decoction for the treatment of gout. PLoS One. 2014;9(1):e85008. https://doi.org/10.1371/journal.pone.0085008
  7. Calitz C, du Plessis L, Gouws C, Steyn D, Steenekamp J, Muller C, et al. Herbal hepatotoxicity: current status, examples, and challenges. Expert opinion on drug metabolism & toxicology. 2015;11(10):1551-65. https://doi.org/10.1517/17425255.2015.1064110
  8. Teschke R. Traditional Chinese Medicine Induced Liver Injury. Journal of clinical and translational hepatology. 2014;2(2):80-94. https://doi.org/10.14218/JCTH.2014.00003
  9. 식품의약품안전처. 식품의약품안전처 고시 제2014-97호 의약품등 안전성 정보관리 규정 제2조(2014. 2. 20).
  10. 한국의약품안전관리원. 약물역학연구 수행사례 나눔터(약수터) 제1호. 2012.
  11. 권영주, 조우근, 한창호. 1개 대학 한방병원에서 EMR을 통해 보고된 한약에 의한 약물유해반응의 현황. 대한한방내과학회지. 2012;33(4):485-97.
  12. 김미경, 한창호. EMR의 자발적 약물부작용보고시스템을 이용한 한약약물유해반응 분석. 대한한의학회지. 2015;36(1):45-60. https://doi.org/10.13048/jkm.15005
  13. 한국 의약품 안전관리원. Available from : https://www.drugsafe.or.kr/ko/index.do
  14. 醫藥品醫療機器統合機構 (Pharmaceuticals and medical devices agency). Available from: http://www.pmda.go.jp/index.html
  15. 國家藥品不良反應監測中心. Available from: http://www.cdr.gov.cn.
  16. 衛生福利部中醫藥司. Available from: http://www.mohw.gov.tw/cht/DOCMAP/.
  17. 香港特別行政區政府 衛生署 藥物辦公室 (Drug Office, Department of Health, The Government of the Hong Kong Speicial Administrative Region (GHKSAR)) Available from : http://www.drugoffice.gov.hk/eps/do/en/healthcare_providers/adr_reporting/reporting_guideline.html.
  18. 정면우, 김영훈, 하지혜, 나한성, 신희정, 박형중, et al. 국내 유해사례 보고자료 관리 및 활용방안 연구. 식품의약품안전처: 2010.
  19. 법제처. 법률 제13320호. 약사법 제2조. (2015.2).
  20. 김윤경. 한의약제제표준화연구. 원광대학교: 식품의약품안전처, 2011 과제번호 : 1475006662.
  21. Itoh T, Sugao M, Chijiwa T, Senda S, Oji T, Ebisawa S. Clinical characteristics of side effects induced by administration of Glycyrrhize radix and Scutellaria radix under the therapy based on Kampo diagnosis in out hospital. Kamp Med. 2010;61(3):299-307. https://doi.org/10.3937/kampomed.61.299
  22. 윤영주, 신병철, 신우진, 장인수. 간손상 관련 한약 안전성 연구의 개선을 위한 한약인성 간손상 조사표 제안. 대한한방내과학회지. 2009;30(1):181-90